This measure would recognize March 2017 as Multiple Myeloma Awareness Month in order to raise awareness of the importance of the ongoing fight against blood cancers.

This measure would recognize March 2017 as Multiple Myeloma Awareness Month in order to raise awareness of the importance of the ongoing fight against blood cancers.

This measure would recognize March 2017 as Multiple Myeloma Awareness Month in order to raise awareness of the importance of the ongoing fight against blood cancers.

WHEREAS, According to the American Cancer Society, multiple myeloma is a blood cancer formed from malignant plasma cells found in the bone marrow; and

WHEREAS, Multiple myeloma is the second most common blood cancer worldwide and currently afflicts more than 100,000 people in the United States; and

WHEREAS, An estimated 30,000 new cases are diagnosed each year; and

WHEREAS, Multiple myeloma is twice as common in African Americans than in Caucasian Americans, and someone with a sibling or parent who is diagnosed with multiple myeloma is four times more likely to be diagnosed; and

WHEREAS, Early symptoms of multiple myeloma may be bone problems, such as bone pain in the back, hips, or skull, types of bone weakness, and the detection of a shortage of red blood cells, white blood cells, and blood platelets; and

WHEREAS, An increased awareness of multiple myeloma for clinicians and the general public will lead to earlier diagnosis and better treatment, allowing people to live longer and with a higher quality of life; and

WHEREAS, The State of California is committed to increase awareness of multiple myeloma and encourages continued investment into blood cancer research, as innovation to achieve early diagnosis and other advancements may lead to the more effective and safer treatments for multiple myeloma patients; now, therefore, be it

Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature recognizes March 2017 as Multiple Myeloma Awareness Month in California in order to raise awareness of the importance of the ongoing fight against blood cancers; and be it further

Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.

WHEREAS, According to the American Cancer Society, multiple myeloma is a blood cancer formed from malignant plasma cells found in the bone marrow; and

WHEREAS, Multiple myeloma is the second most common blood cancer worldwide and currently afflicts more than 100,000 people in the United States; and

WHEREAS, An estimated 30,000 new cases are diagnosed each year; and

WHEREAS, Multiple myeloma is twice as common in African Americans than in Caucasian Americans, and someone with a sibling or parent who is diagnosed with multiple myeloma is four times more likely to be diagnosed; and

WHEREAS, Early symptoms of multiple myeloma may be bone problems, such as bone pain in the back, hips, or skull, types of bone weakness, and the detection of a shortage of red blood cells, white blood cells, and blood platelets; and

WHEREAS, An increased awareness of multiple myeloma for clinicians and the general public will lead to earlier diagnosis and better treatment, allowing people to live longer and with a higher quality of life; and

WHEREAS, The State of California is committed to increase awareness of multiple myeloma and encourages continued investment into blood cancer research, as innovation to achieve early diagnosis and other advancements may lead to the more effective and safer treatments for multiple myeloma patients; now, therefore, be it

Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature recognizes March 2017 as Multiple Myeloma Awareness Month in California in order to raise awareness of the importance of the ongoing fight against blood cancers; and be it further

Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.

WHEREAS, According to the American Cancer Society, multiple myeloma is a blood cancer formed from malignant plasma cells found in the bone marrow; and

WHEREAS, Multiple myeloma is the second most common blood cancer worldwide and currently afflicts more than 100,000 people in the United States; and

WHEREAS, An estimated 30,000 new cases are diagnosed each year; and

WHEREAS, Multiple myeloma is twice as common in African Americans than in Caucasian Americans, and someone with a sibling or parent who is diagnosed with multiple myeloma is four times more likely to be diagnosed; and

WHEREAS, Early symptoms of multiple myeloma may be bone problems, such as bone pain in the back, hips, or skull, types of bone weakness, and the detection of a shortage of red blood cells, white blood cells, and blood platelets; and

WHEREAS, An increased awareness of multiple myeloma for clinicians and the general public will lead to earlier diagnosis and better treatment, allowing people to live longer and with a higher quality of life; and

WHEREAS, The State of California is committed to increase awareness of multiple myeloma and encourages continued investment into blood cancer research, as innovation to achieve early diagnosis and other advancements may lead to the more effective and safer treatments for multiple myeloma patients; now, therefore, be it

Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature recognizes March 2017 as Multiple Myeloma Awareness Month in California in order to raise awareness of the importance of the ongoing fight against blood cancers; and be it further

Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.

SENATE THIRD READING

STR Bill Id:

Author:(Beall)

As Introduced Ver:

Majority vote

SENATE VOTE: 36-0

SUMMARY: Recognizes March 2017 as Multiple Myeloma Awareness Month in order to raise awareness of the importance of the ongoing fight against blood cancers. Specifically, this resolution makes the following legislative findings:

1. Multiple myeloma is a blood cancer formed from malignant plasma cells found in the bone marrow and is the second most common blood cancer worldwide and currently afflicts more than 100,000 people in the United States with an estimated 30,000 new cases diagnosed each year.
2. Multiple myeloma is twice as common in African Americans as in Caucasian Americans, and someone with a sibling or parent who is diagnosed with multiple myeloma is four times more likely to be diagnosed.
3. Early symptoms of multiple myeloma may be bone problems, such as bone pain in the back, hips, or skull, types of bone weakness, and the detection of a shortage of red blood cells, white blood cells, and blood platelets.
4. An increased awareness of multiple myeloma for clinicians and the general public will lead to earlier diagnosis and better treatment, allowing people to live longer and with a higher quality of life.

FISCAL EFFECT: None

Analysis Prepared by: Nicole Willis / RLS. / (916) 319-2800 FN: 0000035

Date of Hearing: March 16, 2017

ASSEMBLY COMMITTEE ON

, Chair

SBPCA Bill Id:

Author:() – As Ver:February 28, 2017

SENATE VOTE: 36-0

SUBJECT:

SUMMARY: Recognizes March 2017 as Multiple Myeloma Awareness Month in order to raise awareness of the importance of the ongoing fight against blood cancers. Specifically, this resolution makes the following legislative findings:

1. Multiple myeloma is a blood cancer formed from malignant plasma cells found in the bone marrow and is the second most common blood cancer worldwide and currently afflicts more than 100,000 people in the United States with an estimated 30,000 new cases diagnosed each year.
2. Multiple myeloma is twice as common in African Americans as in Caucasian Americans, and someone with a sibling or parent who is diagnosed with multiple myeloma is four times more likely to be diagnosed.
3. Early symptoms of multiple myeloma may be bone problems, such as bone pain in the back, hips, or skull, types of bone weakness, and the detection of a shortage of red blood cells, white blood cells, and blood platelets.
4. An increased awareness of multiple myeloma for clinicians and the general public will lead to earlier diagnosis and better treatment, allowing people to live longer and with a higher quality of life.

FISCAL EFFECT: None

REGISTERED SUPPORT / OPPOSITION:

Support

International Myeloma Foundation

Opposition

None on file

Analysis Prepared by:

 THIRD READING 

Bill No: SCR 29

Author: Beall (D)

Introduced: 2/28/17

Vote: 21

SUBJECT: Multiple Myeloma Awareness Month

SOURCE: International Myeloma Foundation

DIGEST:

This resolution recognizes March 2017 as Multiple Myeloma Awareness Month in order to raise awareness of the importance of the ongoing fight against blood cancers.

ANALYSIS: This resolution makes the following legislative findings:

1. According to the American Cancer Society, multiple myeloma is a blood cancer formed from malignant plasma cells found in the bone marrow.
2. Multiple myeloma is twice as common in African Americans than in Caucasian Americans, and someone with a sibling or parent who is diagnosed with multiple myeloma is four times more likely to be diagnosed.
3. Early symptoms of multiple myeloma may be bone problems, such as bone pain in the back, hips, or skull, types of bone weakness, and the detection of a shortage of red blood cells, white blood cells, and blood platelets.
4. An increased awareness of multiple myeloma for clinicians and the general public will lead to earlier diagnosis and better treatment, allowing people to live longer and with a higher quality of life.

This resolution recognizes March 2017 as Multiple Myeloma Awareness Month in California in order to raise awareness of the importance of the ongoing fight against blood cancers.

FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No

SUPPORT: (Verified 3/2/17)

International Myeloma Foundation (source)

OPPOSITION: (Verified 3/2/17)

None received

Prepared by: Karen Chow / SFA / (916) 651-1520

3/2/17 8:53:04

**** END ****